ArticleJournal of personalized medicine2025

Efficacy and Safety of Omalizumab and Dupilumab in Pediatric Patients with Skin Diseases: An Observational Study.

Francesca Galletta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.